Fundraising FoxCatabasis Pharmaceuticals
Cambridge, US · Delaware corporation · 2 known investors
Find your way into Catabasis Pharmaceuticals
Sign up to see every warm intro you have to Catabasis Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Catabasis Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 2
Lightstone VenturesreportedPortola Valley
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$298.2M disclosed across 3 rounds · 2015–2021
▶$175.7MraisedFeb 2021 · 6 investors · PharmaceuticalsRule 506(b)
▶$175.7MraisedFeb 2021 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth BateDirector
- Joanne T. BeckDirector
- Hugh ColeDirector
- Gregg LapointeDirector
- Jonathan ViolinDirector
- Fred CalloriDirector
- Noah ClauserExecutive Officer
- Ben HarshbargerExecutive Officer
- Michael D. KishbauchDirector
- Andrew KomjathyExecutive Officer
- Andrew NicholsExecutive Officer
- Jill C. MilneExecutive Officer, Director
- Joanne DonovanExecutive Officer
- Offering amount
- $175.7M
- Amount sold
- $175.7M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$110MraisedFeb 2021 · 23 investors · PharmaceuticalsRule 506(b)
▶$110MraisedFeb 2021 · 23 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jill C. MilneExecutive Officer, Director
- Joanne DonovanExecutive Officer
- Andrew NicholsExecutive Officer
- Andrew KomjathyExecutive Officer
- Michael D. KishbauchDirector
- Kenneth BateDirector
- Joanne T. BeckDirector
- Hugh ColeDirector
- Gregg LapointeDirector
- Jonathan ViolinDirector
- Fred CalloriDirector
- Noah ClauserExecutive Officer
- Ben HarshbargerExecutive Officer
- Offering amount
- $110M
- Amount sold
- $110M
- Sales commissions
- $5.5M
- Placement agents
- Jefferies LLC
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.4MraisedMar 2015 · 20 investors · PharmaceuticalsRule 506(b)
▶$12.4MraisedMar 2015 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ron LauferDirector
- Nicholas GalakatosDirector
- Kenneth BateDirector
- Jill C. MilneExecutive Officer, Director
- Jean GeorgeDirector
- Michael RossDirector
- Ian SandersonExecutive Officer
- Offering amount
- $20.4M
- Amount sold
- $12.4M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Catabasis Pharmaceuticals?
- Catabasis Pharmaceuticals was founded by Jill C. Milne.
- Who are Catabasis Pharmaceuticals's investors?
- Catabasis Pharmaceuticals's investors include Clarus Ventures, Lightstone Ventures.
- How much funding has Catabasis Pharmaceuticals raised?
- Catabasis Pharmaceuticals has disclosed $298.2M raised across 3 rounds.
- Where is Catabasis Pharmaceuticals headquartered?
- Catabasis Pharmaceuticals is headquartered in Cambridge, US.